Rules allow drug developers to list on the bourse before they sell any products to patients
Related Posts
Li Ka-Shing's Horizons Ventures Invests In Impossible Foods
New Horizon Leads $80M Series B+ Round In Wacai
Huarong shares frozen as chairman placed under investigation
IBM works with firms for cloud computing
China fines payments companies for cross-border forex breaches
Shares tumble to lowest in over 6 months on dismal PMI reading
Yunfeng, SAIF Lead $158M Series D Round In Rong360
Beijing’s foray into the graveyard of empires
As China Fights Corruption, More Downside For Macau Gaming Stocks
Italy football league in talks to hold match in China
